China Oncology ›› 2020, Vol. 30 ›› Issue (10): 733-743.doi: 10.19401/j.cnki.1007-3639.2020.10.003

• Specialists’ Commentary and Article • Previous Articles     Next Articles

Recent advances and prospect in targeted therapy for lung cancer

HONG Shaodong, ZHANG Li   

  1. Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China

  • Online:2020-10-30 Published:2020-11-11
  • Contact: ZHANG Li E-mail:

Abstract: During the past years, targeted agents have dramatically changed the diagnosis and treatment paradigm of lung cancer, which also have significantly improved the survival and quality of life for patients with lung cancer. With the innovations of targeted agents, the optimization of modes of targeted treatment, the exploration of mechanisms of drug resistance and the research and development of novel targets and drugs, the context of targeted therapy in lung cancer is largely enriched. In this paper, we discussed the recent advances and future direction of targeted therapy for driver mutation positive lung cancer.

Key words: Lung cancer, Driver gene, Targeted therapy, Drug resistance